Skip to content
Disclosery

EXANE DERIVATIVES: INTC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on INTC, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 47,794 INTC shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 47,794 shares
    Change vs previous 13F +19,217 shares

    1.03% of the 13F portfolio, value $1,787,579.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 28,577 shares
    Change vs previous 13F +4,063 shares

    0.4% of the 13F portfolio, value $1,416,169.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 24,514 shares
    Change vs previous 13F +22,921 shares

    0.31% of the 13F portfolio, value $1,262,408.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,593 shares
    Change vs previous 13F -509 shares

    0.02% of the 13F portfolio, value $84,871.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,102 shares
    Change vs previous 13F -3,182 shares

    0.03% of the 13F portfolio, value $119,537.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 5,284 shares
    Change vs previous 13F -15,129 shares

    0.1% of the 13F portfolio, value $338,155.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 20,413 shares
    Change vs previous 13F -41,494 shares

    0.31% of the 13F portfolio, value $1,016,912.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 61,907 shares
    Change vs previous 13F not available

    1.05% of the 13F portfolio, value $3,205,411.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).